| Sex-steroids |
|
|
|
|
|
|
|
|
| Testosterone c
|
|
↑ |
|
↑ |
|
|
↓ |
(Nunes et al., 2000, 2001; Prudom et al., 2008; Ross & French, 2011; Ross et al., 2004; Toni E. Ziegler et al., 2011, 2005; T. Ziegler & Snowdon, 2000) |
| Testosterone agonist |
|
↑/↓ |
|
|
|
|
0 |
(Kendrick & Dixson, 1985) |
| Estradiol c
|
|
↑ |
|
|
|
|
|
(L.J. Digby, 1999; Kendrick & Dixson, 1983; Toni E. Ziegler et al., 2005) |
| Estradiol agonist |
|
|
|
|
|
|
↑ |
(Kendrick & Dixson, 1985) |
| Glucocorticoids |
|
|
|
|
|
|
|
|
| Cortisol c
|
|
↑ |
|
↑/0 |
↑ |
↓ |
↓ |
(Fisher-Phelps et al., 2015; Hennessy, Mendoza, Mason, & Moberg, 1995; Nunes et al., 2001; Ross & French, 2011; Ross et al., 2004; Rukstalis & French, 2005; Adam S. Smith et al., 2011) |
| CRH-1 antagonist |
|
|
|
|
↓ |
|
|
(J. A. French et al., 2007) |
| Neuropeptides |
|
|
|
|
|
|
|
|
| Oxytocin c
|
|
↑ |
|
0 |
|
|
|
(Finkenwirth et al., 2015; Fisher-Phelps et al., 2015; C.T. Snowdon et al., 2010) |
| Oxytocin agonist |
|
↑ |
↑ |
|
|
0 |
↑ |
(Cavanaugh et al., 2015, 2014; Mustoe et al., 2015; Saito & Nakamura, 2011; J. H. Taylor & French, 2015) |
| Oxytocin antagonist |
|
↓/0 |
0 |
|
|
↓ |
0 |
(Cavanaugh et al., 2016, 2014; Mustoe et al., 2015; Adam S. Smith et al., 2010) |
| Vasopressin c
|
|
|
|
↑ |
|
|
|
(Fisher-Phelps et al., 2015) |
| Vasopressin agonist |
|
|
↑ |
|
|
|
↑ |
(Jarcho et al., 2011; J. H. Taylor & French, 2015) |
| Dopamine |
|
|
|
|
|
|
|
|
| Neural activity in the reward system |
↓ |
|
|
|
|
|
|
(K. L. Bales et al., 2007) |
| Opioids |
|
|
|
|
|
|
|
|
| MOR agonist |
|
↓ |
|
|
|
|
|
(Ragen et al., 2015, 2013) |
| KOR agonist |
|
|
|
|
0 |
|
|
(Ragen et al., 2015) |
| KOR antagonist |
|
|
|
|
↓ |
|
|
(Ragen et al., 2015) |
| Nonspecific antagonist |
|
↓ |
|
|
|
↑ |
|
(Ragen et al., 2013) |